Media
-
We are excited to announce that Ami Lifesciences will be exhibiting at CPHI Korea!!! Join us from August 27-29, 2024, at COEX,
Aug 27, 2024,
-
We are pleased to announce that Ami Lifesciences will be exhibiting at PharmaConex 2024 in Cairo, Egypt!
Aug 27, 2024,
-
We are thrilled to announce that our Oxcarbazepine has received the Certificate of Suitability (CEP) approval from the EDQM.
Aug 02, 2024,
-
As we prepare for CPhI Milan, we cordially invite you to visit us at Booth No. 1C18 from October 8-10, 2024, at Fiera Milano, Italy.
Aug 02, 2024,
-
We are thrilled to announce that Ami Lifesciences has received the Associated CADIFA approval for our product, Vonoprazan Fumarate.
Aug 02, 2024,
-
We are delighted to share that Ami Lifesciences has been awarded the EcoVadis Gold certification, a recognition that places us among the top performers
Aug 02, 2024,
-
Few hours to go for CPHI China 2024. we look forward to welcoming you to CPHI China and are eager to engage with you in what promises to be an inspiring and productive event.
June 20, 2024,
-
**A Fantastic First Day at CPHI China 2024!** Our Ami Lifesciences team was busy connecting with industry leaders, showcasing our robust API portfolio
June 20, 2024,
-
Ami Lifesciences Pvt. Ltd. on LinkedIn: #cphichina #team #amilifesciences #innovation
June 19-21, 2024,
-
Join us at CPhI Japan 2024, where the world of pharmaceuticals converges to explore innovation, collaboration, and growth opportunities!!!!
Apr 08, 2024
-
We are delighted to inform you that we have received CEP approval for Rivaroxaban, which is used as an anti-coagulating agent,
Apr 08, 2024
-
We are excited to meet our business associates and partners in the DCAT Week in the New York City!!!
Mar 18, 2024
-
We're thrilled to announce that we received CEP approval for Gliclazide. With this approval, we're one step closer
Mar 01, 2024
-
The "15th Asia Pharma Expo" in Dhaka, Bangladesh, is opening today, providing an opportunity to network
Mar 01, 2024
-
We're thrilled to announce the successful filing of the USDMF for Sitagliptin Phosphate Monohydrate! This milestone represents a significant step
Jan 23, 2024
-
Ami Lifesciences family blissfully celebrates the divine homecoming of Lord Ram in Ayodhya with heartfelt prayers and Shobha Yatra.
Jan 23, 2024
-
We are excited to announce the US DMF submission of Mirogablin Besylate to the US FDA.
Jan 01, 2024
-
As we say goodbye to 2023, we pause to reflect on our team's accomplishments. This year has prove.
Jan 01, 2024
-
We will be exhibiting at CPHI & PMEC India PMEC at India Expo Centre & Mart, Greater Noida on November 28-30, 2023.
Nov 22, 2023
-
You are cordially invited to attend CPHI Barcelona 2023 and meet our emerging markets team. We're thrilled to have you in this exclusive space
Oct 17, 2023
-
Mark your calendar to connect with our team at CPHI Barcelona, 2023. Seize the chance to launch ground-breaking collaborative projects.
Oct 17, 2023
-
Join us at CPHI Barcelona from October 24th to 26th!!! Team Ami is excited to welcome you to this vibrant platform and world's
Oct 17, 2023
-
At CPhI Worldwide 2023, the pharmaceutical industry will congregate in Barcelona, and Ami Lifesciences will be leading the charge.
Oct 11, 2023
-
We are thrilled to announce that the USDMF for Finerenone has been submitted to the USFDA; this is the first USDMF for Finerenone API from an Indian
Sep 29, 2023
-
Congratulations to team Ami Lifesciences for being shortlisted as a finalist for the Regulatory Achievement of the Year award at the Global Generics
Sep 28, 2023
-
We will be exhibiting at CPHI Barcelona, 2023, the world's leading pharmaceutical and healthcare exhibition!
Meet our team at booth no. 81C40 during the event.Sep 20, 2023
-
We are very grateful to all our clients and visitors for their time and meaningful discussion during the meetings at PharmaConex 2023.
Sep 08, 2023
-
It's time to say CPhI Korea 2023
Our team is grateful to all the customers and visitors for the meaningful meetings and discussions at our booth.Sep 01, 2023
-
Ami Lifesciences is pleased to announce that it will be exhibiting at CPHI Korea at COEX in Seoul from August 30 to September 1 at booth No. G38B.
Sep 01, 2023
-
We are delighted to announce the successful CADIFA submission of Bempedoic Acid to ANVISA, Brazil. For this API, we are fully backward-integrated
Sep 01, 2023
-
Ami Lifesciences will be exhibiting at Pharmaconex 2023, to be held from September 3 to 5, 2023 at the Egypt International Exhibition Centre in Cairo.
Aug 28, 2023
-
Ami Lifesciences is pleased to announce that it will be exhibiting at CPHI Korea from August 30 to September 1 at COEX in Seoul at booth No. G38B
Aug 22, 2023
-
We are thrilled to announce Ami Lifesciences being the Highest USDMF filer (#14) in H-1 2023 timeframe Globally.
Aug 21, 2023
-
We are delighted to announce that the USDMF for Daprodustat API has been filed with the US FDA.
June 30, 2023
-
Yoga is the fountain of youth. It's exercise, meditation, and philosophy rolled into one.
June 26, 2023
-
Sneak peek of our team at China CPHI, connecting with clients, business partners
June 26, 2023
-
We are happy to be back in China and exhibiting at CPHI China from June 19-21, 2023.
June 19-21, 2023
-
CPHI North America was a success for Ami Lifesciences Pvt Ltd. We appreciate our clients and guests stopping
April 25 to 27, 2023.
-
We are exhibiting at CPHI North America, and you are welcome to visit the Ami Lifesciences
April 25 to 27, 2023.
-
We are pleased to inform that we are now EcoVadis Certified, the most widely recognized international
20 April 2023
-
We are excited to be at CPhI Japan (19-21 April 2023). It will be a pleasure to meet our customers
10 April 2023
-
We will be exhibiting at the CPHI North America Exhibition in Pennsylvania from April 25th to 27th, 2023.
10 April 2023
-
The USDMF for Empagliflozin API submitted to the USFDA. Our expert team created and scaled up a lean process to assist our formulation partners
27 Mar 2023
-
Ami Lifesciences had a very successful DCAT Week, with significant customer meetings and anticipating an incredible path forward.
27 Mar 2023
-
We are pleased to inform you that the USDMF for Edoxaban API has been submitted to the USFDA. Based on our process expertise
27 Mar 2023
-
Mr Varad Nabar, AVP Marketing, will attend DCAT (Drug, Chemical & Associated Technologies Association) Week 2023 in New York
20 - 23 Mar 2023
-
The DCAT (Drug, Chemical & Associated Technologies Association) week is approaching; come meet us and learn more about Ami Lifesciences
20 - 23 Mar 2023
-
Our CEO, Amit Kaptain, will be in New York from March 20th to 23rd for DCAT (Drug, Chemical & Associated Technologies Association) Week 2023.
20 - 23 Mar 2023
-
It gives us great pleasure to announce that the USDMF for Sacubitril Sodium has been submitted to the USFDA. With an innovative development strategy, our team of experts
20 Mar 2023
-
Our innovation efforts have been validated today when our R&D team received Excellence in Research and Development" award.
20 Mar 2023
-
We are pleased to inform you that Sacubitril Valsartan's USDMF has been successfully submitted to the USFDA. Our process experts developed Sacubitril Valsartan
09 Mar 2023
-
We are pleased to announce that the USDMF for Desvenlafaxine Succinate has been submitted to the USFDA.
08 Mar 2023
-
We are glad to share that the US DMF for Sevelamer Hydrochloride was successfully submitted to the USFDA. We have a distinctive advantage
02 Mar 2023
-
We are happy to announce our USDMF filing of Dapagliflozin Amorphous to the USFDA.
02 Mar 2023
-
We are extremely happy to share the successful filling of Febuxostat USDMF with the USFDA.
18 Feb 2023
-
We are happy to share that the US DMF for Sevelamer Carbonate was successfully submitted to the USFDA.
17 Feb 2023
-
We are delighted to announce that the USDMF for Tadalafil was successfully submitted to the USFDA.
17 Feb 2023
